| Thank you to our sponsors. |
|
|
Founded in 2004, BioStrategy Partners is a virtual incubator providing technology and business development services to emerging-stage life sciences companies and university-based research projects in the Greater Philadelphia region. BioSP specializes in offering business guidance and support to first-time entrepreneurs, scientific founders, and university-based principal investigators. For more information, please visit our web site, http://www.biostrategypartners.org.
| |
|
From the Executive Director
Karen J. Hanson, Ph.D. |
|
BioSP is starting 2009 with a new web address! Please visit us now at www.biostrategypartners.org where you'll find information about our KIZ as well as all of our programs and services for life sciences company founder-entrepreneurs and tech transfer offices. You'll also see our growing list of sponsors. We are pleased to welcome KIZ Partner Citizens Bank as a new Gold Sponsor! Michael L. Rainone heads up the Technology & Life Sciences Group and is based at the Citizens Gateway Center in Plymouth Meeting. |
| Practical Knowledge Series:
Upcoming Programs |
|
CFO: Bookkeeper or Financial Leader?
Thursday, February 5, 2009
8:30am to 11:00am
Citizens Bank Gateway Center
3025 Chemical Road
Plymouth Meeting, PA 19462 |
| Welcome New Supporters |
|
|
Kirk A. Reinbold, Ph.D., Principal, MedTech Solutions
Matthew Winters, Senior Vice President, Hub International
Morris Gocial, Partner, Gold Gocial Gerstein LLC |
| Company Profile: OneWorld Biotech, Inc. |
|
In 2006, Dr. Malla Padidam founded OneWorld Biotech, Inc., an R&D partnering company that provides discovery research outsourcing services to pharmaceutical and biotechnology companies and government research institutions. Dr. Padidam, OneWorld's President and a molecular biologist/geneticist with more than 20 years of scientific and entrepreneurial experience, recognized a major business opportunity in this very rapidly growing segment where significant industry-wide reductions in internal research staffs have led to increasing use of outsourcing services for early-stage research programs.
Dr. Padidam also recognized the need for a strong business and marketing strategy to effectively market his new company and to differentiate OneWorld's products and services in an increasingly competitive contract services industry. As a participant in BioStrategy Partners' Corporate Development Program, Dr. Padidam worked with PolySolutions Advisors LLC to develop a detailed business, marketing and financial plan. Using the plan as a foundation, BioSP then engaged the services of Markitects, Inc. who worked with Dr. Padidam to develop marketing messages, brochures (click here to see a sample) and a professionally redesigned website to enhance the company's internet presence, a vital connection to its customer base. "BioSP's Corporate Development Program provided OneWorld Biotech with highly effective and personalized business, financial and marketing coaching at a very early stage when the company needed it most, helping us to create a strong foundation for future growth."
Dr. Padidam has now cmpleted all of his milestones and is the first "graduate" of BioSP's Corporate Development Program. We wish him great success! |
| News From Our Community |
|
Bucks County Community College, a KIZ Partner, is pleased to announce a new program of study beginning in Spring 2009--Biotechnology Certification in Cell and Tissue Culture. Developed by a consortium of industry and academic partners through a grant from the Life Sciences Career Alliance, the certification will benefit current biotechnology workers who want to update their skills as well as students desiring entry-level employment in biotechnology. For more information, please contact Stephen Goshorn, Ph.D., Biotech Coordinator, goshorns@bucks.edu or 215.504.8613.
Jubilant Organosys Ltd, headquartered at Noida, near New Delhi, announced that its Bangalore based subsidiary Jubilant Biosys Ltd, has entered into a drug discovery partnership with BioLeap, LLC, USA. Under this partnership BioLeap and Jubilant will integrate BioLeap's leading edge computational fragment based drug design platform with Jubilant's expertise in chemistry, biology and crystallography to offer a highly competitive preclinical drug development platform. The partnership will provide customers with integrated pre-clinical drug discovery services from lead identification and optimization to IND (Investigational New Drug) candidate selection, for multiple therapeutic areas.
Real Time Dent (formerly Real Time X) successfully showcased at the 11th MIT VC Annual Conference. Real Time Dent was one of 30 early-stage businesses chosen from more than 100 applications from early-stage companies around the world.
MAC Alliance and Mid-Atlantic Diamond Ventures 2009 Company Showcase will be held Friday, January 30 at the Philadelphia Country Club. Interested parties can register at www.fox.temple.edu/madv.
BioSP's KIZ arranged for two affiliated scientists to take advantage of the opportunity offered by Biotech 2008's Innovation Corridor to showcase their technologies.
--Barbara Schick, Ph.D. presented: Design of Novel Concatameric Cationic Heparin-binding Peptides to Control Bleeding Caused by Heparin or Low Molecular Weight Heparin Anticoagulation.
--Laszlo Otvos, Ph.D. presented: A Pharmacologically Improved Agonist of the Leptin Receptor for Metabolic Diseases. | |
|
